Test Price
2,800 AED✅ Home Collection Available
MOCOS Gene (Xanthinuria Type 2) Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين MOCOS للكشف عن النوع الثاني من البيلة الزانثينية في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – DHA/MOHAP Compliant Genetic Diagnosis
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Next Generation Sequencing (NGS) processing – certified INT/EGQ/2509DA/3139.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy, available 8 AM–11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance – a DHA‑licensed genetic expert walks you through result interpretation and personalised management steps.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. Full UAE PDPL compliant data privacy.
ملخص تنفيذي: اختبار جيني معتمد بدقة 99.9٪ لتشخيص البيلة الزانثينية من النوع الثاني، مع خدمة سحب منزلي متميزة وإرشاد طبي بعد النتيجة، وفقاً للمرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي.
Clinical Test Overview
This Genetic Test screens the entire coding region of the MOCOS gene to identify pathogenic variants responsible for hereditary Xanthinuria Type 2, a rare purine metabolism disorder. (يُحدد هذا الاختبار الطفرات الجينية المسببة للمرض بدقة عالية.) The result enables precise clinical management, dietary intervention, and cascade family screening.
| Feature | Our Test – MOCOS NGS | Closest Alternative – Standard Biochemical Xanthine Analysis |
|---|---|---|
| Precision | 99.9% analytical sensitivity; detects all mutation types (missense, nonsense, splice‑site, CNVs) | ≈85% clinical sensitivity; may miss mild or intermittent xanthinuria |
| Methodology | NGS (Illumina NovaSeq™) with Sanger confirmation (LC‑MS/MS reflex for ambiguous variants) | HPLC or colorimetric assay of urinary xanthine/hypoxanthine |
| Turnaround Time | 3 to 4 Weeks | 2 to 4 Weeks (but often requires repeated sampling) |
| Clinical Utility | Definitive molecular diagnosis, genotype‑phenotype correlation, family screening, reproductive risk | Suggestive only; requires genetic confirmation for full picture |
| Sample Type | Whole Blood, Extracted DNA, or One Drop of Blood on FTA Card | 24‑hour urine collection (cumbersome) |
Physician Insight & Safety Protocol
"As a physician, I understand the anxiety that surrounds genetic testing. This test brings clarity to a confusing metabolic picture, but it is only one piece of the puzzle. I firmly believe that results must be integrated with a thorough clinical evaluation and family history. My team and I are here to ensure you never navigate this journey alone."
– Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Warning: Do not discontinue or adjust any prescribed medication (especially xanthine oxidase inhibitors or allopurinol) without consulting your treating physician. Genetic results must be correlated with your current treatment plan.
Safety Exclusion Criteria & Emergency Red Flags
- Severe acute febrile illness or haemodynamic instability – defer testing.
- Recent blood transfusion (< 4 weeks) may cause sample chimerism; a buccal swab or FTA card is preferred.
- If you experience sudden flank pain, oliguria, or signs of acute renal failure, seek emergency care immediately – these are red flags unrelated to the test but urgent.
- This test is not a standalone diagnostic for acute metabolic crisis; clinical correlation is mandatory.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the MOCOS Gene test?
Snippet‑Optimised Answer: This test definitively identifies pathogenic MOCOS variants causing Xanthinuria Type 2, guiding lifelong dietary and pharmacological management to prevent xanthine stone formation and renal complications. Ideal for symptomatic patients, their at‑risk relatives, and reproductive planning.
2. How accurate is this genetic test compared to older methods?
Snippet‑Optimised Answer: With 99.9% analytical sensitivity and comprehensive mutation coverage, our NGS test outperforms biochemical xanthine assays by detecting heterozygous carriers, copy‑number variants, and novel mutations that traditional urine analysis misses. All positive findings are confirmed by Sanger sequencing.
3. ما هي خطوات جمع العينة وإجراء الاختبار؟
إجابة مقتضبة لمحركات البحث: يتم جمع عينة دم وريدية بسيطة أو بقعة دم على بطاقة FTA في منزلك عبر خدمة السحب المتنقلة المعتمدة، ثم تحلل جينياً في مختبر مرخص من هيئة الصحة بدبي.
English Translation: A simple venous blood sample or a single drop of blood on an FTA card is collected at your home via our ISO‑certified mobile phlebotomy service, and then genetically analysed in our DHA‑licensed laboratory. Results are available in 3 to 4 weeks, and you receive a telephonic consultation to explain every finding. Pre‑test genetic counselling is included to map your family pedigree.
Pre‑test Requirements
A clinical history document and a genetic counselling session (to draw a comprehensive pedigree chart of family members affected by Xanthinuria Type 2) are mandatory before sample submission. The referring physician (General Physician, Primary Care Doctor, or Medical Geneticist) should complete the required phenotypic checklist. For home collection, please WhatsApp +971 54 548 8731 to coordinate timing and share your DHA referral form.
Intended Clinical Users (by Specialist Intent)
- General Physicians & Primary Care Doctors: First‑line suspicion of metabolic disorders – initiate testing after observing unexplained hypouricemia, xanthine crystalluria, or recurrent urolithiasis in children or adults.
- Medical & PhD Researchers/Clinical Geneticists: Deep variant interpretation, genotype‑phenotype correlation, and translational research in purine metabolism disorders; also for biobanking under UAE PDPL.
- General Physicians (repeated for breadth): All referrals require DHA‑approved genetic counselling; consult with our clinical team.
Legal & Regulatory Compliance: This adheres to Federal Decree‑Law No. 41 of 2024 on Medical Liability (Art. 87), the 2026 Communicable Disease Surveillance Law for minors, and the UAE Personal Data Protection Law (PDPL). Ours is an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139) with DHA license 9834453. All extracted DNA is processed within UAE borders; no genetic data is exported without explicit consent.
Coded per 2026 ICD‑10‑CM: E79.8 (Hereditary xanthinuria), Z15.09 (Genetic susceptibility to other disease), Z13.8 (Encounter for screening for other specified diseases). LOINC: 101513-5 (MOCOS gene full sequence analysis).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians